- Details
- Description
LuciLena (Lenacapavir Injection) is a long-acting antiviral medicine containing lenacapavir, an HIV-1 capsid inhibitor. It works by targeting the HIV capsid protein and interfering with multiple stages of the viral life cycle, thereby helping prevent HIV replication.
The injectable formulation of lenacapavir is used as part of combination antiretroviral therapy for the treatment of HIV-1 infection in appropriate patients. Due to its long-acting properties, it can be administered at extended intervals according to the prescribed treatment schedule.
LuciLena should be administered under the supervision of a qualified healthcare professional. Treatment should be used as part of an appropriate antiretroviral regimen and according to the patient's clinical condition and treatment requirements.
